Lippman Evan
SEC CIK 2062834 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Business Development | 25.6K | — | $2.16M | 3 | 2026-05-14 | 2026-08-17 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-19 16:00 | 2026-08-17 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Lippman Evan | EVP, Business Development | S - Sale | $36.57 | -18.6K | 25.6K | -42% | -$680.3K |
| DMT | 2026-05-18 16:02 | 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Lippman Evan | EVP, Business Development | M - OptEx | — | +85.8K | 80.1K | New | — |
| DMT | 2026-05-18 16:02 | 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Lippman Evan | EVP, Business Development | S - Sale+OE | $35.58 | -41.7K | 44.2K | -49% | -$1.48M |
Purchase Sale Sale after option exercise All abbreviations